Predicting the outcome of ankylosing spondylitis therapy
- Author
- Nathan Vastesaeger (UGent) , Désirée van der Heijde, Robert D Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U Rahman, Ben Dijkmans, Piet Geusens, Bert Vander Cruyssen (UGent) , Eduardo Collantes, Joachim Sieper and Jürgen Braun
- Organization
- Keywords
- Immunology, Biochemistry, Genetics and Molecular Biology(all), Immunology and Allergy, Rheumatology, DISEASE-ACTIVITY INDEX, NECROSIS FACTOR TREATMENT, PLACEBO-CONTROLLED TRIAL, MAJOR CLINICAL-RESPONSE, ACTIVITY SCORE ASDAS, ANTI-TNF THERAPY, INFLIXIMAB, SAFETY, EPIDEMIOLOGY, IMPROVEMENT
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 360.13 KB
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 45.41 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8500055
- MLA
- Vastesaeger, Nathan, et al. “Predicting the Outcome of Ankylosing Spondylitis Therapy.” ANNALS OF THE RHEUMATIC DISEASES, vol. 70, no. 6, 2011, pp. 973–81, doi:10.1136/ard.2010.147744.
- APA
- Vastesaeger, N., van der Heijde, D., Inman, R. D., Wang, Y., Deodhar, A., Hsu, B., … Braun, J. (2011). Predicting the outcome of ankylosing spondylitis therapy. ANNALS OF THE RHEUMATIC DISEASES, 70(6), 973–981. https://doi.org/10.1136/ard.2010.147744
- Chicago author-date
- Vastesaeger, Nathan, Désirée van der Heijde, Robert D Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U Rahman, et al. 2011. “Predicting the Outcome of Ankylosing Spondylitis Therapy.” ANNALS OF THE RHEUMATIC DISEASES 70 (6): 973–81. https://doi.org/10.1136/ard.2010.147744.
- Chicago author-date (all authors)
- Vastesaeger, Nathan, Désirée van der Heijde, Robert D Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U Rahman, Ben Dijkmans, Piet Geusens, Bert Vander Cruyssen, Eduardo Collantes, Joachim Sieper, and Jürgen Braun. 2011. “Predicting the Outcome of Ankylosing Spondylitis Therapy.” ANNALS OF THE RHEUMATIC DISEASES 70 (6): 973–981. doi:10.1136/ard.2010.147744.
- Vancouver
- 1.Vastesaeger N, van der Heijde D, Inman RD, Wang Y, Deodhar A, Hsu B, et al. Predicting the outcome of ankylosing spondylitis therapy. ANNALS OF THE RHEUMATIC DISEASES. 2011;70(6):973–81.
- IEEE
- [1]N. Vastesaeger et al., “Predicting the outcome of ankylosing spondylitis therapy,” ANNALS OF THE RHEUMATIC DISEASES, vol. 70, no. 6, pp. 973–981, 2011.
@article{8500055,
author = {{Vastesaeger, Nathan and van der Heijde, Désirée and Inman, Robert D and Wang, Yanxin and Deodhar, Atul and Hsu, Benjamin and Rahman, Mahboob U and Dijkmans, Ben and Geusens, Piet and Vander Cruyssen, Bert and Collantes, Eduardo and Sieper, Joachim and Braun, Jürgen}},
issn = {{0003-4967}},
journal = {{ANNALS OF THE RHEUMATIC DISEASES}},
keywords = {{Immunology,Biochemistry,Genetics and Molecular Biology(all),Immunology and Allergy,Rheumatology,DISEASE-ACTIVITY INDEX,NECROSIS FACTOR TREATMENT,PLACEBO-CONTROLLED TRIAL,MAJOR CLINICAL-RESPONSE,ACTIVITY SCORE ASDAS,ANTI-TNF THERAPY,INFLIXIMAB,SAFETY,EPIDEMIOLOGY,IMPROVEMENT}},
language = {{eng}},
number = {{6}},
pages = {{973--981}},
title = {{Predicting the outcome of ankylosing spondylitis therapy}},
url = {{http://doi.org/10.1136/ard.2010.147744}},
volume = {{70}},
year = {{2011}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: